查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2166736

寵物絕育疫苗市場：全球市場預測，2026-2032年

Pet Contraceptive Vaccine Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，寵物避孕疫苗市場規模將達到 5.6732 億美元，複合年成長率為 7.48%。

主要市場統計數據
基準年 2025 3.4232億美元
預計年份：2026年 3.6899億美元
預測年份 2032 5.6732億美元
複合年成長率 (%) 7.48%

寵物絕育疫苗：研究範圍執行摘要

寵物絕育疫苗代表了一種透過免疫介導機製而非依賴傳統手術或常規荷爾蒙注射來控制伴侶動物繁殖的新方法。該領域融合了獸醫學、動物福利、生殖生物學、免疫學和族群管理等多個學科。由於某一領域的進展並不一定能自動轉化為廣泛的臨床應用，因此評估必須區分實驗室研發、獸醫認可、臨床證據、飼主接受度和實用化這幾個面向。

正在重塑獸醫生殖保健的變革

獸醫學中的生殖管理受到以下因素的影響：對微創治療方案的需求、對動物福利日益成長的關注，以及對意外懷孕負責任管理的必要性。當手術難以進行、恢復時間令人擔憂或需要暫時性生殖管理時，寵物絕育疫苗可能會有所幫助。然而，產品研發必須解決諸多挑戰，例如藥效持續時間、可逆性、物種特異性安全性、給藥方案、生殖健康監測以及飼主對治療限制的理解。監管機構對臨床證據和治療後後續觀察的要求仍然是產品推廣應用的關鍵。

人工智慧有潛力加速發展和應用。

人工智慧可以透過幫助研究人員分析免疫反應數據、識別候選抗原、建立劑量反應模型以及確定實驗室研究中的安全挑戰優先級，為該領域提供支持。在臨床環境中，數據驅動型工具可以輔助患者篩選、治療提醒、不利事件監測和生殖健康記錄解讀。這些應用需要具有代表性的獸醫資料集、透明的檢驗、網路安全措施和專家監督。人工智慧產生的預測應作為獸醫檢查、知情同意和監管審查的補充，而非替代。

區域獸醫和動物福利體系的見解

北美地區擁有完善的伴侶動物獸醫基礎設施，並積極探討非手術繁殖管理方法。拉丁美洲在都市區節育手術服務可近性方面可能存在顯著差異，與北美類似，但成本效益和服務能力是關鍵限制因素。歐洲強調動物福利、可追溯性和實證獸醫學，並對安全性、可逆性和合規性有強烈的要求。中東地區的獸醫體系和寵物飼養模式各不相同，需要根據當地情況制定教育和服務模式。非洲的優先事項包括確保服務可及性、控制種群數量以及將其與更廣泛的動物健康計劃相結合。亞太地區擁有發達的獸醫市場，但法規、文化和服務環境極為多樣化，因此必須根據具體國別進行實施。

來自東協、金磚國家、歐盟、七國集團、海灣合作理事會和北約的集團層面見解。

在東協成員國，協調一致的獸醫教育和靈活的服務模式，能夠反映出各國不同的監管能力和寵物醫療服務取得途徑，可能大有裨益。在金磚國家，鑑於各國在研究能力、動物衛生體系和財政能力方面存在顯著差異，統一的證據標準和在地化生產能力可能至關重要。歐盟特別重視成員國之間通用的監管原則、動物福利保障和一致的證據要求。七國集團（G7）國家通常擁有完善的臨床研究和獸醫基礎設施，能夠支援嚴格的評估，同時保持對安全性和透明度的高期望。海灣合作理事會（GCC）市場可能需要根據其不同的進口、許可和獸醫框架量身定做的服務模式。北約並非獸醫監管集團，但其成員國擁有不同的動物衛生體系，因此，各國的準備工作、後勤保障和公共部門協調可能會影響獸醫技術的取得。

針對不同國家的產品開發與部署考量因素

在澳大利亞，由於社區地域分散，藥品分發、後續跟進以及獲得當地獸醫服務的機會至關重要。巴西和墨西哥可能需要針對獸醫基礎設施和經濟能力的區域差異而製定相應的服務模式。加拿大和美國擁有完善的伴侶動物照護體系，但其實施取決於臨床證據、專家指導和監管部門的批准。中國、印度、日本和韓國擁有數量龐大的伴侶動物，且法規、文化和臨床環境各不相同，因此需要根據當地情況制定相應的證據和溝通方案。在法國、德國、義大利、西班牙和英國，獸醫標準、動物福利和合理用藥都備受重視。俄羅斯的實施環境同樣取決於國內的監管流程、獸醫基礎設施以及取得檢驗產品的途徑。

獸醫學和動物健康領域領導者的策略重點

產業領導者應優先進行設計完善、適合物種的臨床試驗，以評估疫苗的有效性、持續時間、可逆性、對生育能力的影響以及短期和長期安全性。研發項目應儘早吸收獸醫、監管機構、動物收容所、繁殖者和寵物飼主參與，以明確可接受的使用情境和溝通需求。切實可行的方案應包含明確的指導方針，例如冷鍊和儲存需求、給藥訓練、後續程序、不利事件報告以及是否以及何時需要再次給藥。此外，領導者應避免將疫苗接種視為節育手術的萬靈藥，並應投資於獨立的動物福利評估、透明的指南披露以及公平的獲取途徑。

寵物避孕疫苗領域評估的調查方法

一項全面的評估應結合對同行評審的獸醫學和免疫學文獻、監管出版刊物、臨床試驗記錄、動物福利指南以及公開技術文件的系統性回顧。證據應按物種、介入機制、研發階段、研究設計、終點品質、追蹤期和已報告的安全性結果進行審查。區域分析應比較北美、拉丁美洲、歐洲、中東和非洲以及亞太地區的監管環境、獸醫服務能力、文化背景和准入因素，同時也應分別考慮東協、金磚國家、歐盟、七國集團、海灣合作理事會和北約等組織。國家層級的解讀應包括澳洲、巴西、加拿大、中國、法國、德國、印度、義大利、日本、墨西哥、俄羅斯、韓國、西班牙、英國和美國，但組織成員資格不應被視為產品上市準備就緒的證據。

結論：證據和負責任的實施是至關重要的因素。

寵物絕育疫苗在伴侶動物繁殖管理中可能是一種有價值的選擇，但其實際意義取決於檢驗的安全性、可靠的持續時間、明確的可逆性、監管部門的批准以及獸醫的信任。儘管地區和國家差異會影響疫苗的取得、教育和服務提供，但負責任地管理疫苗接種可以提高研究效率和臨床監測。最佳途徑是以實證為基礎的研發，並將動物福利、知情的飼主選擇、專家監督和透明的治療後監測置於實施的核心。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 寵物避孕疫苗市場：依動物類型分類

  • 貓
    • 家貓
    • 貓咪在戶外玩耍
  • 狗

第8章：寵物避孕疫苗市場：依產品類型分類

  • 荷爾蒙系統
    • 注射藥物
    • 口服
  • 非荷爾蒙系統
    • 基於DNA的
    • 基於蛋白質

第9章：寵物避孕疫苗市場：依通路分類

  • 網路藥房
  • 零售藥房
  • 動物診所

第10章：寵物避孕疫苗市場：依最終用戶分類

  • 動物收容所
  • 寵物飼主
  • 動物醫院

第11章 寵物避孕疫苗市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章 寵物避孕疫苗市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章：寵物避孕疫苗市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale SA
  • Elanco Animal Health Incorporated
  • Hester Biosciences Limited
  • HIPRA, SA
  • Merck & Co., Inc.
  • SenesTech, Inc.
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc.

第16章 主要專家

Product Code: MRR-1F6B5542863B

The Pet Contraceptive Vaccine Market is projected to grow by USD 567.32 million at a CAGR of 7.48% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 342.32 million
Estimated Year [2026] USD 368.99 million
Forecast Year [2032] USD 567.32 million
CAGR (%) 7.48%

Pet Contraceptive Vaccines: Executive Summary Scope

Pet contraceptive vaccines represent an emerging approach to managing reproduction in companion animals through immune-mediated mechanisms rather than conventional surgical procedures or routine hormonal administration. The field sits at the intersection of veterinary medicine, animal welfare, reproductive biology, immunology, and population management. Evaluation should distinguish between laboratory development, veterinary authorization, clinical evidence, owner acceptance, and practical deployment, because progress in one area does not automatically establish broad clinical use.

Shifts Reshaping Veterinary Reproductive Management

Veterinary reproductive management is being influenced by demand for less invasive options, growing attention to animal welfare, and the need for responsible control of unwanted litters. Pet contraceptive vaccines may become relevant where surgery is difficult to access, recovery time is a concern, or temporary fertility management is preferred. However, product development must address duration of effect, reversibility, species-specific safety, dosing schedules, reproductive-health monitoring, and owner understanding of treatment limitations. Regulatory expectations for clinical evidence and post-treatment surveillance remain central to adoption.

How Artificial Intelligence Could Accelerate Development and Use

Artificial intelligence can support this field by helping researchers analyze immune-response data, identify candidate antigens, model dose-response relationships, and prioritize safety questions for laboratory investigation. In clinical settings, data-driven tools may assist with patient selection, treatment reminders, adverse-event surveillance, and interpretation of reproductive-health records. These applications require representative veterinary datasets, transparent validation, cybersecurity controls, and professional oversight. AI-generated predictions should complement-not replace-veterinary examination, informed consent, and regulatory review.

Regional Insights Across Veterinary and Animal-Welfare Systems

North America is characterized by established companion-animal healthcare infrastructure and active discussion of non-surgical reproductive control. Latin America may see relevance where access to sterilization services varies substantially between urban and rural areas, although affordability and delivery capacity are important constraints. Europe's emphasis on welfare, traceability, and evidence-based veterinary practice places strong weight on safety, reversibility, and regulatory compliance. The Middle East includes diverse veterinary systems and pet-ownership patterns, requiring locally appropriate education and service models. Africa's priorities may include access, population management, and integration with broader animal-health programs. Asia-Pacific combines advanced veterinary markets with highly diverse regulatory, cultural, and service environments, making country-specific implementation essential.

Group-Level Signals from ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN members may benefit from coordinated veterinary education and adaptable delivery models that reflect varied regulatory capacity and pet-care access. BRICS economies present substantial diversity in research capabilities, animal-health systems, and affordability, making harmonized evidence standards and local manufacturing capabilities potentially important. The European Union places particular emphasis on common regulatory principles, welfare safeguards, and consistent evidence requirements across member states. G7 countries generally have mature clinical research and veterinary infrastructures, supporting rigorous evaluation while maintaining high expectations for safety and transparency. GCC markets may require service models aligned with varied import, licensing, and veterinary-practice frameworks. NATO is not a veterinary regulatory bloc, but its member-country coverage includes diverse animal-health systems where preparedness, logistics, and public-sector coordination can influence access to veterinary technologies.

Country-Level Considerations for Product Development and Adoption

Australia's geographically dispersed communities make distribution, follow-up, and rural veterinary access important considerations. Brazil and Mexico may require delivery models that address regional differences in veterinary capacity and affordability. Canada and the United States have sophisticated companion-animal care systems, but adoption would depend on clinical evidence, professional guidance, and regulatory authorization. China, India, Japan, and South Korea combine significant companion-animal populations with distinct regulatory, cultural, and clinical environments, requiring localized evidence and communication. France, Germany, Italy, Spain, and the United Kingdom place strong emphasis on veterinary standards, animal welfare, and informed use. Russia's adoption environment would likewise depend on domestic regulatory pathways, veterinary infrastructure, and access to validated products.

Strategic Priorities for Veterinary and Animal-Health Leaders

Industry leaders should prioritize well-designed, species-appropriate clinical studies that measure efficacy, duration, reversibility, fertility outcomes, and short- and long-term safety. Development programs should engage veterinarians, regulators, shelters, breeders, and pet owners early to clarify acceptable use cases and communication needs. Practical plans should include cold-chain or storage requirements, administration training, follow-up protocols, adverse-event reporting, and clear guidance on whether and when repeat treatment is appropriate. Leaders should also avoid positioning vaccination as a universal replacement for sterilization and should invest in independent welfare assessment, transparent evidence disclosure, and equitable access strategies.

Research Methodology for Assessing the Pet Contraceptive Vaccine Field

A robust assessment combines structured review of peer-reviewed veterinary and immunology literature, regulatory publications, clinical-trial records, animal-welfare guidance, and publicly available technical documentation. Evidence should be screened by species, intervention mechanism, development stage, study design, endpoint quality, duration of follow-up, and reported safety outcomes. Geographic analysis should compare regulatory conditions, veterinary-service capacity, cultural context, and access considerations across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific, while separately considering ASEAN, BRICS, the European Union, G7, GCC, and NATO groupings. Country interpretation should cover Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Russia, South Korea, Spain, the United Kingdom, and the United States without treating group membership as proof of market readiness.

Conclusion: Evidence and Responsible Implementation Are Decisive

Pet contraceptive vaccines offer a potentially valuable addition to companion-animal reproductive management, but their practical significance depends on validated safety, dependable duration, clear reversibility expectations, regulatory acceptance, and veterinary confidence. Regional and country differences will shape access, education, and service delivery, while AI may improve research efficiency and clinical monitoring when governed responsibly. The strongest path forward is evidence-led development that places animal welfare, informed owner choice, professional oversight, and transparent post-treatment surveillance at the center of implementation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Pet Contraceptive Vaccine Market, by Animal Type

  • 7.1. Introduction
  • 7.2. Cats
    • 7.2.1. Indoor Cats
    • 7.2.2. Outdoor Cats
  • 7.3. Dogs

8. Pet Contraceptive Vaccine Market, by Product Type

  • 8.1. Introduction
  • 8.2. Hormonal
    • 8.2.1. Injectable
    • 8.2.2. Oral
  • 8.3. Non-Hormonal
    • 8.3.1. DNA-Based
    • 8.3.2. Protein-Based

9. Pet Contraceptive Vaccine Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Online Pharmacies
  • 9.3. Retail Pharmacies
  • 9.4. Veterinary Clinics

10. Pet Contraceptive Vaccine Market, by End User

  • 10.1. Introduction
  • 10.2. Animal Shelters
  • 10.3. Pet Owners
  • 10.4. Veterinary Hospitals

11. Pet Contraceptive Vaccine Market, by Region

  • 11.1. Introduction
  • 11.2. Asia-Pacific
  • 11.3. North America
  • 11.4. Latin America
  • 11.5. Europe
  • 11.6. Middle East
  • 11.7. Africa

12. Pet Contraceptive Vaccine Market, by Group

  • 12.1. Introduction
  • 12.2. ASEAN
  • 12.3. GCC
  • 12.4. European Union
  • 12.5. BRICS
  • 12.6. G7
  • 12.7. NATO

13. Pet Contraceptive Vaccine Market, by Country

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. United Kingdom
  • 13.7. Germany
  • 13.8. France
  • 13.9. Russia
  • 13.10. Italy
  • 13.11. Spain
  • 13.12. China
  • 13.13. India
  • 13.14. Japan
  • 13.15. Australia
  • 13.16. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2025
  • 14.2. Market Concentration Analysis, 2025
    • 14.2.1. Concentration Ratio (CR)
    • 14.2.2. Herfindahl Hirschman Index (HHI)
  • 14.3. Recent Developments & Impact Analysis, 2025
  • 14.4. Product Portfolio Analysis, 2025
  • 14.5. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Boehringer Ingelheim International GmbH
  • 15.2. Ceva Sante Animale S.A.
  • 15.3. Elanco Animal Health Incorporated
  • 15.4. Hester Biosciences Limited
  • 15.5. HIPRA, S.A.
  • 15.6. Merck & Co., Inc.
  • 15.7. SenesTech, Inc.
  • 15.8. Vetoquinol S.A.
  • 15.9. Virbac S.A.
  • 15.10. Zoetis Inc.

16. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Pet Contraceptive Vaccine Market, Years Considered for the Study
  • FIGURE 2. Global Pet Contraceptive Vaccine Market, Research Design
  • FIGURE 3. Global Pet Contraceptive Vaccine Market, Research Framework
  • FIGURE 4. Global Pet Contraceptive Vaccine Market, Data Triangulation
  • FIGURE 5. Global Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Pet Contraceptive Vaccine Market Size, by Animal Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Pet Contraceptive Vaccine Market Size, by Animal Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Pet Contraceptive Vaccine Market Size, by Product Type, 2025 vs 2032 (%)
  • FIGURE 9. Global Pet Contraceptive Vaccine Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2025 vs 2032 (%)
  • FIGURE 11. Global Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Pet Contraceptive Vaccine Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 13. Global Pet Contraceptive Vaccine Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Pet Contraceptive Vaccine Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 15. Global Pet Contraceptive Vaccine Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Pet Contraceptive Vaccine Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 17. Global Pet Contraceptive Vaccine Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 18. Global Pet Contraceptive Vaccine Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Pet Contraceptive Vaccine Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Pet Contraceptive Vaccine Market Segmentation & Coverage
  • TABLE 2. Global Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 4. Global Cats Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Cats Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Cats Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Indoor Cats Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Indoor Cats Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Indoor Cats Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Outdoor Cats Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Outdoor Cats Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Outdoor Cats Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Dogs Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Dogs Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Dogs Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 17. Global Hormonal Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 18. Global Hormonal Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 19. Global Hormonal Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 20. Global Injectable Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 21. Global Injectable Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 22. Global Injectable Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 23. Global Oral Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 24. Global Oral Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 25. Global Oral Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 26. Global Non-Hormonal Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 27. Global Non-Hormonal Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 28. Global Non-Hormonal Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 29. Global DNA-Based Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 30. Global DNA-Based Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 31. Global DNA-Based Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 32. Global Protein-Based Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 33. Global Protein-Based Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 34. Global Protein-Based Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 35. Global Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 36. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 37. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 38. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 39. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 40. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 41. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 42. Global Veterinary Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 43. Global Veterinary Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 44. Global Veterinary Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 45. Global Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 46. Global Animal Shelters Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 47. Global Animal Shelters Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 48. Global Animal Shelters Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 49. Global Pet Owners Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 50. Global Pet Owners Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 51. Global Pet Owners Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 52. Global Veterinary Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 53. Global Veterinary Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 54. Global Veterinary Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 55. Global Pet Contraceptive Vaccine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 56. Asia-Pacific Pet Contraceptive Vaccine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 57. Asia-Pacific Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 58. Asia-Pacific Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
  • TABLE 59. Asia-Pacific Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 60. Asia-Pacific Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
  • TABLE 61. Asia-Pacific Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
  • TABLE 62. Asia-Pacific Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 63. Asia-Pacific Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 64. North America Pet Contraceptive Vaccine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 65. North America Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 66. North America Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
  • TABLE 67. North America Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 68. North America Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
  • TABLE 69. North America Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
  • TABLE 70. North America Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 71. North America Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 72. Latin America Pet Contraceptive Vaccine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 73. Latin America Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 74. Latin America Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
  • TABLE 75. Latin America Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 76. Latin America Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
  • TABLE 77. Latin America Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
  • TABLE 78. Latin America Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 79. Latin America Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 80. Europe Pet Contraceptive Vaccine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 81. Europe Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 82. Europe Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
  • TABLE 83. Europe Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 84. Europe Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
  • TABLE 85. Europe Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
  • TABLE 86. Europe Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 87. Europe Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 88. Middle East Pet Contraceptive Vaccine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 89. Middle East Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 90. Middle East Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
  • TABLE 91. Middle East Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 92. Middle East Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
  • TABLE 93. Middle East Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
  • TABLE 94. Middle East Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 95. Middle East Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 96. Africa Pet Contraceptive Vaccine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 97. Africa Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 98. Africa Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
  • TABLE 99. Africa Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 100. Africa Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
  • TABLE 101. Africa Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
  • TABLE 102. Africa Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 103. Africa Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 104. Global Pet Contraceptive Vaccine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 105. ASEAN Pet Contraceptive Vaccine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 106. ASEAN Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 107. ASEAN Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
  • TABLE 108. ASEAN Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 109. ASEAN Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
  • TABLE 110. ASEAN Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
  • TABLE 111. ASEAN Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 112. ASEAN Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 113. GCC Pet Contraceptive Vaccine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 114. GCC Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 115. GCC Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
  • TABLE 116. GCC Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 117. GCC Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
  • TABLE 118. GCC Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
  • TABLE 119. GCC Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 120. GCC Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 121. European Union Pet Contraceptive Vaccine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 122. European Union Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 123. European Union Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
  • TABLE 124. European Union Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 125. European Union Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
  • TABLE 126. European Union Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
  • TABLE 127. European Union Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 128. European Union Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 129. BRICS Pet Contraceptive Vaccine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 130. BRICS Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 131. BRICS Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
  • TABLE 132. BRICS Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 133. BRICS Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
  • TABLE 134. BRICS Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
  • TABLE 135. BRICS Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 136. BRICS Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 137. G7 Pet Contraceptive Vaccine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 138. G7 Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 139. G7 Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
  • TABLE 140. G7 Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 141. G7 Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
  • TABLE 142. G7 Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
  • TABLE 143. G7 Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 144. G7 Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 145. NATO Pet Contraceptive Vaccine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 146. NATO Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 147. NATO Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
  • TABLE 148. NATO Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 149. NATO Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
  • TABLE 150. NATO Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
  • TABLE 151. NATO Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 152. NATO Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 153. Global Pet Contraceptive Vaccine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 154. United States Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 155. United States Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 156. United States Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
  • TABLE 157. United States Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 158. United States Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
  • TABLE 159. United States Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
  • TABLE 160. United States Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 161. United States Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 162. Canada Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 163. Canada Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 164. Canada Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
  • TABLE 165. Canada Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 166. Canada Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
  • TABLE 167. Canada Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
  • TABLE 168. Canada Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 169. Canada Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 170. Mexico Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 171. Mexico Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 172. Mexico Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
  • TABLE 173. Mexico Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 174. Mexico Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
  • TABLE 175. Mexico Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
  • TABLE 176. Mexico Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 177. Mexico Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 178. Brazil Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 179. Brazil Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 180. Brazil Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
  • TABLE 181. Brazil Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 182. Brazil Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
  • TABLE 183. Brazil Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
  • TABLE 184. Brazil Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 185. Brazil Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 186. United Kingdom Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 187. United Kingdom Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 188. United Kingdom Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
  • TABLE 189. United Kingdom Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 190. United Kingdom Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
  • TABLE 191. United Kingdom Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
  • TABLE 192. United Kingdom Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 193. United Kingdom Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 194. Germany Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 195. Germany Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 196. Germany Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
  • TABLE 197. Germany Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 198. Germany Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
  • TABLE 199. Germany Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
  • TABLE 200. Germany Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 201. Germany Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 202. France Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 203. France Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 204. France Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
  • TABLE 205. France Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 206. France Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
  • TABLE 207. France Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
  • TABLE 208. France Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 209. France Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 210. Russia Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 211. Russia Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 212. Russia Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
  • TABLE 213. Russia Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 214. Russia Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
  • TABLE 215. Russia Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
  • TABLE 216. Russia Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 217. Russia Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 218. Italy Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 219. Italy Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 220. Italy Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
  • TABLE 221. Italy Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 222. Italy Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
  • TABLE 223. Italy Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
  • TABLE 224. Italy Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 225. Italy Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 226. Spain Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 227. Spain Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 228. Spain Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
  • TABLE 229. Spain Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 230. Spain Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
  • TABLE 231. Spain Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
  • TABLE 232. Spain Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 233. Spain Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 234. China Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 235. China Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 236. China Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
  • TABLE 237. China Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 238. China Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
  • TABLE 239. China Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
  • TABLE 240. China Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 241. China Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 242. India Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 243. India Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 244. India Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
  • TABLE 245. India Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 246. India Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
  • TABLE 247. India Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
  • TABLE 248. India Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 249. India Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 250. Japan Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 251. Japan Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 252. Japan Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
  • TABLE 253. Japan Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 254. Japan Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
  • TABLE 255. Japan Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
  • TABLE 256. Japan Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 257. Japan Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 258. Australia Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 259. Australia Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 260. Australia Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
  • TABLE 261. Australia Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 262. Australia Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
  • TABLE 263. Australia Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
  • TABLE 264. Australia Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 265. Australia Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 266. South Korea Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
  • TABLE 267. South Korea Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
  • TABLE 268. South Korea Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
  • TABLE 269. South Korea Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 270. South Korea Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
  • TABLE 271. South Korea Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
  • TABLE 272. South Korea Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 273. South Korea Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 274. Global Pet Contraceptive Vaccine Market Share, by Key Player, 2025
  • TABLE 275. Global Pet Contraceptive Vaccine Market, Key Experts